KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Revenue (2016 - 2025)

Historic Revenue for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $89.8 million.

  • National Health Investors' Revenue rose 832.25% to $89.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $355.6 million, marking a year-over-year increase of 810.84%. This contributed to the annual value of $335.2 million for FY2024, which is 479.81% up from last year.
  • Latest data reveals that National Health Investors reported Revenue of $89.8 million as of Q3 2025, which was up 832.25% from $90.7 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Revenue ranged from a high of $90.7 million in Q2 2025 and a low of $59.9 million during Q2 2022
  • For the 5-year period, National Health Investors' Revenue averaged around $79.0 million, with its median value being $80.1 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first crashed by 1941.48% in 2022, then skyrocketed by 3001.22% in 2023.
  • National Health Investors' Revenue (Quarter) stood at $69.7 million in 2021, then grew by 1.44% to $70.7 million in 2022, then grew by 12.45% to $79.5 million in 2023, then rose by 7.92% to $85.8 million in 2024, then rose by 4.77% to $89.8 million in 2025.
  • Its last three reported values are $89.8 million in Q3 2025, $90.7 million for Q2 2025, and $89.3 million during Q1 2025.